Stock Quote, Chart, News

Symbol Company Name Latest Time Prev Close Latest Price Change $ Change % 52 Wk High 52 Wk Low YTD Chg% Volume
ALLOAllogene TherapeuticsDecember 10, 201826.5226.520.240.9135.5521.676.99621972


Morgan Stanley upgrades Teva and Bausch in premarket analyst action

2018-11-05 08:47

Fate Therapeutics (NASDAQ: FATE ) initiated with Buy rating and $17 (15% upside) at Jefferies. More news on: Fate Therapeutics, Inc., Allogene Therapeutics, Alkermes plc, Healthcare stocks news, Stocks on the move, , Read more … ... by SeekingAlpha


Sector: Healthcare

Industry: Biotechnology


©, All Right Reversed.

Market data provided by IEX Group Inc. The information provided by is not investment advice. Trading and investing in financial markets involves risk. You are responsible for your own investment decisions.

New stock charting and analyzer software coming soon, please stay tuned, if you want to go to old site, click Here.